超酸抑制NSCLC的进展通过诱导ATG13介导的自和亡
Mingming Jin1, Yuqing Lou1, Xiaoshuo Wang1
1Shanghai Key Laboratory of Molecular Imaging, Jiading District Central Hospital Affiliated Shanghai University of Medicine and Health Sciences, Shanghai 201318, China.
Cellular immunology
|April 18, 2025
概括
超氧化物是一种天然化合物,通过促进自和亡,有效地抑制非小细胞肺癌 (NSCLC) 的进展. 这项研究揭示了超化物.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 非小细胞肺癌 (NSCLC) 仍然是一个主要的全球健康问题,死亡率高.
- 尽管取得了进展,但对抗NSCLC的新生物治疗药物仍然非常需要.
- 这项研究探讨了hyperoside作为治疗NSCLC的治疗剂的潜力.
研究的目的:
- 为了研究超氧化物对非小细胞肺癌 (NSCLC) 进展的影响.
- 阐明高氧化物在NSCLC中发挥抗癌作用的潜在机制.
主要方法:
- 使用殖民地形成试验和细胞计数工具包-8.8进行细胞增殖的评估.
- 细胞迁移使用Transwell测试进行了评估.
- 活体瘤生长在皮下异种移植模型中被研究,通过蛋白质组学,免疫组织化学和免疫光学探索分子机制.
主要成果:
- 过氧化物治疗在体外和体内显著抑制NSCLC细胞迁移,增殖和瘤生长.
- 在NSCLC细胞中,过氧化物诱导的亡和S相细胞周期停止.
- 过氧化物促进了与自相关的蛋白13 (ATG13) 介导的自,增强了NSCLC的亡.
结论:
- 过氧化物通过促进ATG13表达和增强自抑制NSCLC的进展.
- 这些发现突显了hyperoside作为NSCLC治疗策略的潜力,通过调节自和亡来调节NSCLC.
- 对肺癌的基于高酸盐的疗法进行进一步的研究是有必要的.
更多相关视频
09:10siRNA Electroporation to Modulate Autophagy in Herpes Simplex Virus Type 1-Infected Monocyte-Derived Dendritic Cells
Published on: October 28, 2019
7.1K
00:06An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
8.7K
相关概念视频
02:49Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
01:31The Intrinsic Apoptotic Pathway
5.7K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
5.7K